
Franklin Resources’s Enanta Pharmaceuticals ENTA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-25,593
| Closed | -$289K | – | 2942 |
|
2024
Q3 | $289K | Sell |
25,593
-586
| -2% | -$6.63K | ﹤0.01% | 2495 |
|
2024
Q2 | $340K | Sell |
26,179
-2,887
| -10% | -$37.4K | ﹤0.01% | 2387 |
|
2024
Q1 | $507K | Buy |
+29,066
| New | +$507K | ﹤0.01% | 2228 |
|
2023
Q2 | – | Sell |
-4,994
| Closed | -$202K | – | 2725 |
|
2023
Q1 | $202K | Sell |
4,994
-31
| -0.6% | -$1.25K | ﹤0.01% | 1998 |
|
2022
Q4 | $234K | Sell |
5,025
-952
| -16% | -$44.3K | ﹤0.01% | 1949 |
|
2022
Q3 | $309K | Buy |
+5,977
| New | +$309K | ﹤0.01% | 1837 |
|
2022
Q1 | – | Sell |
-2,761
| Closed | -$206K | – | 2463 |
|
2021
Q4 | $206K | Buy |
+2,761
| New | +$206K | ﹤0.01% | 2229 |
|
2018
Q3 | – | Sell |
-268,025
| Closed | -$31.1M | – | 1523 |
|
2018
Q2 | $31.1M | Sell |
268,025
-17,775
| -6% | -$2.06M | 0.02% | 657 |
|
2018
Q1 | $23.1M | Sell |
285,800
-31,900
| -10% | -$2.58M | 0.01% | 745 |
|
2017
Q4 | $18.6M | Buy |
317,700
+117,700
| +59% | +$6.91M | 0.01% | 810 |
|
2017
Q3 | $9.36M | Buy |
+200,000
| New | +$9.36M | ﹤0.01% | 961 |
|
2014
Q1 | – | Sell |
-299,000
| Closed | -$8.16M | – | 1537 |
|
2013
Q4 | $8.16M | Sell |
299,000
-231,700
| -44% | -$6.32M | ﹤0.01% | 1033 |
|
2013
Q3 | $12.2M | Buy |
530,700
+50,800
| +11% | +$1.16M | 0.01% | 928 |
|
2013
Q2 | $8.5M | Buy |
+479,900
| New | +$8.5M | ﹤0.01% | 974 |
|